About us

Collaborating Institutions and Societies

Utilizamos cookies para optimizar nuestro sitio web y nuestro servicio.

Funcional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferencias

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Estadísticas

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

A radically new approach to Alzheimer's Disease

Tetraneuroncorporate video

Our history

Tetraneuron was founded

Identification of therapeutic target. E2F4

Beginning of the proof of concept

Validation of therapeutic target: E2F4DN

Identification of the Leading Compound

Validation of the Leading Compound

Validation of the Leading Compound

Analysis of biological processes modulated by E2F4DN

Method validation of AAV9-E2F4DN

Beginning of preclinical regulatory Phase

Tetraneuron is a Spanish gene therapy biotech company with a focus on brain and neurodegenerative conditions

Our team

Cristina Sánchez Puelles. PhD

Morgan Ramón Landrau

Alberto Garrido

Vanesa Cano

Collaborating Institutions and Societies

About us

A radically new approach to Alzheimer's Disease

Tetraneuroncorporate video

Our history

Tetraneuron was founded

Identification of therapeutic target. E2F4

Beginning of the proof of concept

Validation of therapeutic target: E2F4DN

Identification of the Leading Compound

Validation of the Leading Compound

Validation of the Leading Compound

Analysis of biological processes modulated by E2F4DN

Method validation of AAV9-E2F4DN

Beginning of preclinical regulatory Phase

Tetraneuron is a Spanish gene therapy biotech company with a focus on brain and neurodegenerative conditions

Our team

Mari Carmen Álvarez. PhD

Cristina Sánchez Puelles. PhD

Marika Russo. PhD

Alvaro Pascual-Leone. PhD

José María Frade. PhD

Noelia López Sánchez. PhD

David Mor

Morgan Ramón Landrau

Alberto Garrido

Vanesa Cano

Alonso Fernández Nistal, PhD

Vicente Martínez Fernández. MD.PhD. MSc

Ángel Lucio Pereira

Collaborating Institutions and Societies